Blomqvist et al. assessed three potential biomarkers for cancer stem cells, viz., aldehyde dehydrogenase 1 (ALDH1), sex determining region Y-box 2 (SOX2), and stage-specific embryonic antigen-4 (SSEA-4) [39]. The gene discussed is ALDH1A1; the disease is cancer.